Spinal disc regenerative composition and method of manufacture and use
View Patent ↗The present invention provides a novel way to replenish the disc using retooled disc compositions to repair degenerative discs. There is no better source of proteoglycans than the actual disc material ( 6 ) itself. To this end, there has been developed a technique to remove the nucleus pulposus and retool the morphology of the nucleus pulposus to create a powder material ( 10 ) that is dry and can be stored at room temperature for long periods of time. This powder ( 10 ) can then be reconstituted with a variety of fluids, the most suitable being normal saline or lactated ringers to form a flowable mixture ( 20 ).
1. An aqueous spinal disc regenerative composition suitable for injection, wherein the aqueous composition comprises:
a hydrated composition comprising freeze-dried micronized nucleus pulposus in a fluid, produced by a method consisting of:
(i) providing normal human cadaveric intervertebral discs;
(ii) separating the nucleus pulposus from the annulus fibrosus of the normal human cadaveric intervertebral discs;
(iii) drying the nucleus pulposus;
(iv) micronizing the dried nucleus pulposus by pulverizing in a cryomill at a low temperature into particles sized less than 400 microns;
(v) freeze-drying the nucleus pulposus, wherein said freeze-drying occurs during step (iii), between steps (iii) and (iv), and/or after step (iv); and then
(vi) mixing the freeze-dried micronized nucleus pulposus with the fluid thereby producing the hydrated composition.
2. The aqueous spinal disc regenerative composition of claim 1 wherein the freeze-dried micronized nucleus pulposus provided for mixing in step (vi) is in the form of a powder.
3. The aqueous spinal disc regenerative composition of claim 1 wherein the micronized freeze-dried nucleus pulposus has proteoglycan molecules.
4. The aqueous spinal disc regenerative composition of claim 1 wherein the micronized freeze-dried nucleus pulposus has been dried to less than 5% moisture content prior to being rehydrated.
5. The aqueous spinal disc regenerative composition of claim 1 wherein the aqueous composition further comprises one or more of the following: stem cells, micronized amnion, platelet-rich plasma, growth factors, genetically altered cells that produce glycosaminoglycans, collagen Type 1 and glucose.
6. The aqueous spinal disc regenerative composition of claim 1 wherein the micronized material of dried nucleus pulposus has water absorbed by the proteoglycan molecules depleted from the freeze-dried nucleus pulposus.
7. An aqueous spinal disc regenerative composition suitable for injection, wherein the aqueous composition comprises:
a hydrated composition comprising freeze-dried micronized nucleus pulposus in a fluid, produced by a method consisting of:
(i) providing normal human cadaveric intervertebral discs;
(ii) separating the nucleus pulposus from the annulus fibrosus of the normal human cadaveric intervertebral discs;
(iii) drying the nucleus pulposus;
(iv) micronizing the dried nucleus pulposus by pulverizing in a cryomill at a low temperature into particles sized less than 400 microns;
(v) freeze-drying the nucleus pulposus, wherein said freeze-drying occurs during step (iii), between steps (iii) and (iv), and/or after step (iv);
(vi) mixing the freeze-dried micronized nucleus pulposus with the fluid thereby producing the hydrated composition;
wherein the freeze-dried micronized nucleus pulposus provided for mixing in step (vi) is in the form of a powder; and
mixing one or more of stem cells that are derived from marrow, fat, blood or interspinous ligaments; micronized amnion; platelet-rich plasma; and/or growth factors encapsulated in pharmacologically active microspheres, with the powdered freeze-dried micronized nucleus pulposus prior to step (vi), or with the hydrated composition after step (vi).
8. The composition of claim 1 wherein the normal human cadaveric intervertebral discs are intervertebral discs aseptically recovered from cadaveric spine segments from T9 to LS.
9. A composition consisting of:
(a) a syringe or injectable device which is capable of being inserted into a damaged disc to be treated; and
(b) a hydrated composition consisting of freeze-dried micronized nucleus pulposus in a fluid, produced by a method consisting of:
(i) providing normal human cadaveric intervertebral discs;
(ii) separating the nucleus pulposus from the annulus fibrosus of the normal human cadaveric intervertebral discs;
(iii) drying the nucleus pulposus;
(iv) micronizing the dried nucleus pulposus by placing the dried material in a cryomill at low temperature and pulverizing the dried nucleus pulposus into particles sized less than 400 microns into a powder;
(v) freeze-drying the nucleus pulposus, wherein said freeze-drying occurs during step (iii), between steps (iii) and (iv), and/or after step (iv); and then
(vi) mixing the freeze-dried micronized nucleus pulposus with the fluid, thereby producing the hydrated composition and mixing one or more of stem cells that are derived from marrow, fat, blood or interspinous ligaments; micronized amnion; platelet-rich plasma; and/or growth factors encapsulated in pharmacologically active microspheres, with the powdered freeze-dried micronized nucleus pulposus prior to step (vi), or with the hydrated composition after step (vi);
wherein the (b) hydrated composition with one or more stem cells is contained within the (a) syringe or injectable device; and
wherein the (b) hydrated composition has a viscosity which permits it to flow through a cannula.